A phase I randomized therapeutic MVA-B vaccination improves the magnitude and quality of the T cell immune responses in HIV-1-infected subjects on HAART

dc.contributor

Universitat de Vic - Universitat Central de Catalunya. Càtedra de la Sida i Malalties Relacionades

dc.contributor.author

Gómez, Carmen E.

dc.contributor.author

Perdiguero, Beatriz

dc.contributor.author

García Arriaza, Juan

dc.contributor.author

Cepeda, Victoria

dc.contributor.author

Sánchez-Sorzano, Carlos Óscar

dc.contributor.author

Mothe, B.

dc.contributor.author

Jiménez, José Luis

dc.contributor.author

Muñoz Fernández, María Ángeles

dc.contributor.author

Gatell, J.M.

dc.contributor.author

López Bernaldo de Quirós, Juan Carlos

dc.contributor.author

Brander, Christian

dc.contributor.author

Garcia, Felipe

dc.contributor.author

Esteban, Mariano

dc.date

2015

dc.identifier

Elena Gomez, C., Perdiguero, B., Garcia-Arriaza, J., Cepeda, V., Oscar Sanchez-Sorzano, C., Mothe, B., et al. (2015). A phase I randomized therapeutic MVA-B vaccination improves the magnitude and quality of the T cell immune responses in HIV-1-infected subjects on HAART. PLoS One, 10(11), e0141456

dc.identifier

1932-6203

dc.identifier

http://hdl.handle.net/10854/4418

dc.identifier

https://doi.org/10.1371/journal.pone.0141456

dc.identifier.uri

http://hdl.handle.net/10854/4418

dc.description

dc.format

application/pdf

dc.language

eng

dc.publisher

Plos One

dc.rights

Aquest document està subjecte a aquesta llicència Creative Commons

dc.rights

http://creativecommons.org/licenses/by/3.0/es/

dc.rights

info:eu-repo/semantics/openAccess

dc.subject

Sida -- Tractament

dc.subject

VIH (Virus)

dc.title

A phase I randomized therapeutic MVA-B vaccination improves the magnitude and quality of the T cell immune responses in HIV-1-infected subjects on HAART

dc.type

info:eu-repo/semantics/article

dc.type

info:eu-repo/publishedVersion